Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
2D SESSION
H. R. 6609
To provide for the immediate procurement of COVID–19 medical testing
components, materials, and supplies under the Defense Production Act
of 1950.
IN THE HOUSE OF REPRESENTATIVES
APRIL 23, 2020
Mr. PANETTA (for himself, Mr. BROWN of Maryland, Ms. JUDY CHU of Cali-
fornia, Mr. CISNEROS, Mr. DEFAZIO, Mr. ESPAILLAT, Ms. GABBARD, Mr.
GRIJALVA, Mr. HASTINGS, Mr. HUFFMAN, Mr. KILMER, Mr. LOEBSACK,
Mr. MALINOWSKI, Mr. SEAN PATRICK MALONEY of New York, Ms.
MENG, Mr. NADLER, Mrs. NAPOLITANO, Ms. NORTON, Mr. PAYNE, Mr.
PHILLIPS, Miss RICE of New York, Mr. RUPPERSBERGER, Mr. RUSH,
Mr. SCHNEIDER, Ms. SEWELL of Alabama, Mr. SIRES, Ms. SPANBERGER,
Mr. SUOZZI, and Mr. VELA) introduced the following bill; which was re-
ferred to the Committee on Financial Services
A BILL
To provide for the immediate procurement of COVID–19
medical testing components, materials, and supplies
under the Defense Production Act of 1950.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Immediate COVID
4
Testing Procurement Act.’’
5
VerDate Sep 11 2014
21:49 Apr 27, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6609.IH
H6609
kjohnson on DSK79L0C42PROD with BILLS
2
•HR 6609 IH
SEC. 2. IMMEDIATE PURCHASE ORDERS OF COVID–19 MED-
1
ICAL TESTING COMPONENTS, MATERIALS,
2
AND SUPPLIES.
3
(a) IN GENERAL.—Not later than 24 hours after the
4
date of the enactment of this Act, the President shall issue
5
any necessary purchase orders for a program of the high-
6
est national urgency (commonly known as a ‘‘DX’’ pur-
7
chase order) pursuant to Department of Defense Directive
8
4400.1 to procure all necessary components, materials,
9
and supplies to conduct molecular and serological
10
COVID–19 medical testing nationwide under authorities
11
provided by the Defense Production Act of 1950 (50
12
U.S.C. 4501 et seq.).
13
(b) APPROVAL
OR AUTHORIZATION.—All compo-
14
nents, materials, and supplies described in subsection (a)
15
must have received prior approval of the Center for Dis-
16
ease Control and Prevention or have received emergency
17
use authorization from the Food and Drug Administration
18
for the detection of coronavirus disease 2019 (commonly
19
known as ‘‘COVID–19’’).
20
(c) WAIVER
OF
REQUIREMENTS
RELATING
TO
21
SHORTFALLS AND NOTIFICATIONS.—The requirements of
22
sections 301(d)(1)(A) and 303(a)(6) of the Defense Pro-
23
duction
Act
of
1950
(50
U.S.C.
4531(d)(1)(A);
24
4533(a)(6)) are waived for purposes of this section.
25
VerDate Sep 11 2014
21:49 Apr 27, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6609.IH
H6609
kjohnson on DSK79L0C42PROD with BILLS
3
•HR 6609 IH
(d) FUNDING.—Amounts available in the Defense
1
Production Act Fund (established under section 304 of
2
the Defense Production Act of 1950 (50 U.S.C. 4534))
3
shall be made available for purchases made under this sec-
4
tion.
5
Æ
VerDate Sep 11 2014
21:49 Apr 27, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6609.IH
H6609
kjohnson on DSK79L0C42PROD with BILLS